Reports
Reports
Sale
The global urinalysis market attained a value of about USD 2.32 billion in 2023 driven by the rising cases urinary tract infection and geriatric population across the globe. The market is further expected to grow in the forecast period of 2024-2032 at a CAGR of 6.7% to reach nearly USD 4.15 billion by 2032.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
A urinalysis is one of the most common diagnostic tests worldwide which helps evaluate health problems, like urinary system infections, kidney issues, and diabetes. It does this by analyzing urine samples. The analysis is based on parameters such as color, clarity, glucose and protein concentration, pH, and red/white blood cells and crystals. They are part of physical, chemical, and microscopic assessment. Urinalysis is non-invasive and offers valuable health information. It has been recognized as basic diagnostic tool as it helps in making effective decisions for treatment and early disease evaluation.
Growing Geriatric Population to Boost the Market Growth of Urinalysis
The global market for urinalysis is rising, which can be largely attributed to aging demographics of the population. They stem from the growing elderly population in developed and developing countries. This demographic factor is further complemented by the rising prevalence of chronic diseases, which requires urinalysis as an effective diagnostic technologies to evacuate disease prognosis.
Rising Cases of Urinary Tract Infection to Boost Urinalysis Market Demand
The market is growing significantly due to the rising cases of urinary tract infections (UTIs), especially in developing countries. UTIs have many health implications. Pregnant women are at particularly risk if not diagnosed early. So, the use urinalysis in diagnosing the infection is highly utilized in pregnant women. Such instances are expected to boost the market for urinalysis in the forecast period.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Key Trends | Impact |
Increasing Adoption of Point-of-Care Testing | There is a growing trend towards using point of care testing, owing to its prompt nature of result delivery. Healthcare providers often rely on the data with minimal lag time. |
Rising Awareness Towards Preventive Healthcare | There has been a shift towards preventive measures that focus on early disease identification. This has led to a huge demand for regular urinalysis and other early prevention measures. |
Rising Prevalence of Chronic Diseases | The rising incidence of chronic diseases like diabetes, kidney issues, and liver disease is boosting urinalysis market demand. Urinalysis is highly important to keep track of such conditions along with effective disease management. |
Technological Advancements in Urinalysis Devices | Modern automated and digital urinalysis devices are emerging in the market. They greatly improve the accuracy and speed of the diagnosis. Such advanced devices help get a much better analysis of urine, which can be crucial to recommend an effective treatment to patients. |
In April 2023, Withings unveiled its new product, U-Scan, aimed at revolutionizing home urine analysis. The product is placed in the toilet and does not need test strips and sample containers. It features interchangeable cartridges. It interprets hormone level and predicts ovulation windows. It is also enabled with the U-Scan Nutri Balance formula which finds specific gravity, pH, vitamin C, and ketones for a metabolic scan. It is one of the most innovative devices and lets people monitor their health through a smartphone apps or a web interface.
Market Breakup by Product
Market Break by Applications
Market Breakup by Modality
Market Breakup by End User
Market Breakup by Region
Instruments are Expected to Lead Market Share Based on Product Types
The global urinalysis market, based on product types is divided broadly divided into instruments and consumables. Instruments are further divided into biochemical urine analyzers, automated urine sediment analyzers, point-of-care urine analyzers while consumables encompass reagents, disposables, dipsticks, pregnancy, and fertility kits. Instruments are likely to hold a notable market share in the forecast period. Instruments play a crucial role in urinalysis and are expected to lead the market share in the forecast period, driven by increased technological advancements aimed to offer better patient outcomes.
Market Breakup Based on End User set to Witness Market Growth
The market segmentation also covers the end-user segment, which comprises hospitals, diagnostic laboratories, home care settings, and others. The hospital segment is anticipated to hold a significant market share in the coming years. This can be attributed to the increased healthcare capacity and patient volume in facilities, leading to increased usage of modern urinalysis systems. The home care setting segment is likely to witness high growth rate, triggered by a preference for user-friendly urinalysis test kits, as they are comfortable and easy to use.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
This regional market includes North America, Europe, Asia Pacific, Latin America, the Middle East, and Africa. North America is expected to lead the market share based as the application of urinalysis is high in the region. The high incidence of urinalysis can be attributed to an aging population and rising chronic kidney diseases in the region. High healthcare expenditure and presence of major industry players is amongst major driving forces.
The Asia Pacific market is expected to grow at a rapid pace in coming years. This can be due to the entrance of new players, evolving healthcare system and growing demand for diagnostic solutions in the region.
The key features of the market report include patent analysis and strategic initiatives such as partnerships, and collaborations analysis by the leading players. The major companies in the market are as follows:
Abbott Laboratories
It is based out of Chicago, USA and was founded in 1888. It provides a full set of urine tests. Some of the products are the i-STAT System, Afinion 2 Analyzer, and CLINITEK Advantus.
Sysmex Corporation
Established in 1968 and headquartered in Japan. It has a business in diagnostics. This is especially true for in urinalysis systems. They offer the UF-5000/UF-4000, the UC-3500, and the UN-Serie.
ACON Laboratories Inc.
It is a private diagnostics and medical device company, based in California, United States. It was established in 1996. Some products include Mission® U500 Urine Analyzer, the Mission® Expert U120 Urine Analyzer, and the Mission® Urinalysis Reagent Strips.
Bio-Rad Laboratories Inc.
It was founded in 1952 in Berkeley, California and specializes in delivering better urinalysis. Their main products are the D-10 Hemoglobin Testing System, the URISYS 1100® Urine Analyzer, and Liquichek Urinalysis Control.
Other companies in the market include ARKRAY Inc., Siemens AG, Thermo Fisher Scientific Inc., 77 Elektronika Kft, F. Hoffmann-La Roche AG, and Beckman Coulter, Inc.
Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.
REPORT FEATURES | DETAILS |
Base Year | 2023 |
Historical Period | 2017-2023 |
Forecast Period | 2024-2032 |
Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
Breakup by Product |
|
Breakup by Applications |
|
Breakup by Modality |
|
Breakup by End User |
|
Breakup by Region |
|
Market Dynamics |
|
Supplier Landscape |
|
Companies Covered |
|
*While we strive to always give you current and accurate information, the numbers depicted on the website are indicative and may differ from the actual numbers in the main report. At Expert Market Research, we aim to bring you the latest insights and trends in the market. Using our analyses and forecasts, stakeholders can understand the market dynamics, navigate challenges, and capitalize on opportunities to make data-driven strategic decisions.
1 Preface
1.1 Objectives of the Study
1.2 Key Assumptions
1.3 Report Coverage – Key Segmentation and Scope
1.4 Research Methodology
2 Executive Summary
3 Global Urinalysis Market Overview
3.1 Global Urinalysis Market Historical Value (2017-2023)
3.2 Global Urinalysis Market Forecast Value (2024-2032)
4 Vendor Positioning Analysis
4.1 Key Vendors
4.2 Prospective Leaders
4.3 Niche Leaders
4.4 Disruptors
5 Global Urinalysis Market Landscape*
5.1 Global Urinalysis: Developers Landscape
5.1.1 Analysis by Year of Establishment
5.1.2 Analysis by Company Size
5.1.3 Analysis by Region
5.2 Global Urinalysis: Product Landscape
5.2.1 Analysis by Product
5.2.2 Analysis by Modality
6 Global Urinalysis Market Dynamics
6.1 Market Drivers and Constraints
6.2 SWOT Analysis
6.2.1 Strengths
6.2.2 Weaknesses
6.2.3 Opportunities
6.2.4 Threats
6.3 PESTEL Analysis
6.3.1 Political
6.3.2 Environmental
6.3.3 Social
6.3.4 Technological
6.3.5 Ethical
6.3.6 Legal
6.4 Porter’s Five Forces Model
6.4.1 Bargaining Power of Suppliers
6.4.2 Bargaining Power of Buyers
6.4.3 Threat of New Entrants
6.4.4 Threat of Substitutes
6.4.5 Degree of Rivalry
6.5 Key Demand Indicators
6.6 Key Price Indicators
6.7 Industry Events, Initiatives, and Trends
6.8 Value Chain Analysis
7 Global Urinalysis Market Segmentation (2017-2032)
7.1 Global Urinalysis Market (2017-2032) by Product
7.1.1 Market Overview
7.1.2 Instruments
7.1.2.1 Biochemical urine analyzers
7.1.2.2 Automated urine sediment analyzers
7.1.2.3 Point-of-care urine analyzers
7.1.3 Consumables
7.1.3.1 Reagents
7.1.3.2 Disposables
7.1.3.3 Dipsticks
7.1.3.4 Pregnancy and fertility kits
7.2 Global Urinalysis Market (2017-2032) by Applications
7.2.1 Market Overview
7.2.2 Urinary Tract Infections
7.2.3 Kidney Diseases
7.2.4 Diabetes
7.2.5 Liver Diseases
7.2.6 Pregnancy and Fertility
7.2.7 Others
7.3 Global Urinalysis Market (2017-2032) by Modality
7.3.1 Market Overview
7.3.2 Portable
7.3.3 Standalone
7.3.4 Bench Top
7.4 Global Urinalysis Market (2017-2032) by End User
7.4.1 Market Overview
7.4.2 Hospital
7.4.3 Diagnostic Laboratories
7.4.4 Home Care Setting
7.4.5 Others
7.5 Global Urinalysis Market (2017-2032) by Region
7.5.1 Market Overview
7.5.2 North America
7.5.3 Europe
7.5.4 Asia Pacific
7.5.5 Latin America
7.5.6 Middle East and Africa
8 North America Urinalysis Market (2017-2032)
8.1 North America Urinalysis Market (2017-2032) by Product
8.1.1 Market Overview
8.1.2 Instruments
8.1.2.1 Biochemical urine analyzers
8.1.2.2 Automated urine sediment analyzers
8.1.2.3 Point-of-care urine analyzers
8.1.3 Consumables
8.1.3.1 Reagents
8.1.3.2 Disposables
8.1.3.3 Dipsticks
8.1.3.4 Pregnancy and fertility kits
8.2 North America Urinalysis Market (2017-2032) by Applications
8.2.1 Market Overview
8.2.2 Urinary Tract Infections
8.2.3 Kidney Diseases
8.2.4 Diabetes
8.2.5 Liver Diseases
8.2.6 Pregnancy and Fertility
8.2.7 Others
8.3 North America Urinalysis Market (2017-2032) by Modality
8.3.1 Market Overview
8.3.2 Portable
8.3.3 Standalone
8.3.4 Bench Top
8.4 North America Urinalysis Market (2017-2032) by Country
8.4.1 United States of America
8.4.2 Canada
9 Europe Urinalysis Market (2017-2032)
9.1 Europe Urinalysis Market (2017-2032) by Product
9.1.1 Market Overview
9.1.2 Instruments
9.1.2.1 Biochemical urine analyzers
9.1.2.2 Automated urine sediment analyzers
9.1.2.3 Point-of-care urine analyzers
9.1.3 Consumables
9.1.3.1 Reagents
9.1.3.2 Disposables
9.1.3.3 Dipsticks
9.1.3.4 Pregnancy and fertility kits
9.2 Europe Urinalysis Market (2017-2032) by Applications
9.2.1 Market Overview
9.2.2 Urinary Tract Infections
9.2.3 Kidney Diseases
9.2.4 Diabetes
9.2.5 Liver Diseases
9.2.6 Pregnancy and Fertility
9.2.7 Others
9.3 Europe Urinalysis Market (2017-2032) by Modality
9.3.1 Market Overview
9.3.2 Portable
9.3.3 Standalone
9.3.4 Bench Top
9.4 Europe Urinalysis Market (2017-2032) by Country
9.4.1 United Kingdom
9.4.2 Germany
9.4.3 France
9.4.4 Italy
9.4.5 Others
10 Asia Pacific Urinalysis Market (2017-2032)
10.1 Asia Pacific Urinalysis Market (2017-2032) by Product
10.1.1 Market Overview
10.1.2 Instruments
10.1.2.1 Biochemical urine analyzers
10.1.2.2 Automated urine sediment analyzers
10.1.2.3 Point-of-care urine analyzers
10.1.3 Consumables
10.1.3.1 Reagents
10.1.3.2 Disposables
10.1.3.3 Dipsticks
10.1.3.4 Pregnancy and fertility kits
10.2 Asia Pacific Urinalysis Market (2017-2032) by Applications
10.2.1 Market Overview
10.2.2 Urinary Tract Infections
10.2.3 Kidney Diseases
10.2.4 Diabetes
10.2.5 Liver Diseases
10.2.6 Pregnancy and Fertility
10.2.7 Others
10.3 Asia Pacific Urinalysis Market (2017-2032) by Modality
10.3.1 Market Overview
10.3.2 Portable
10.3.3 Standalone
10.3.4 Bench Top
10.4 Asia Pacific Urinalysis Market (2017-2032) by Country
10.4.1 China
10.4.2 Japan
10.4.3 India
10.4.4 ASEAN
10.4.5 Australia
10.4.6 Others
11 Latin America Urinalysis Market (2017-2032
11.1 Latin America Urinalysis Market (2017-2032) by Product
11.1.1 Market Overview
11.1.2 Instruments
11.1.2.1 Biochemical urine analyzers
11.1.2.2 Automated urine sediment analyzers
11.1.2.3 Point-of-care urine analyzers
11.1.3 Consumables
11.1.3.1 Reagents
11.1.3.2 Disposables
11.1.3.3 Dipsticks
11.1.3.4 Pregnancy and fertility kits
11.2 Latin America Urinalysis Market (2017-2032) by Applications
11.2.1 Market Overview
11.2.2 Urinary Tract Infections
11.2.3 Kidney Diseases
11.2.4 Diabetes
11.2.5 Liver Diseases
11.2.6 Pregnancy and Fertility
11.2.7 Others
11.3 Latin America Urinalysis Market (2017-2032) by Modality
11.3.1 Market Overview
11.3.2 Portable
11.3.3 Standalone
11.3.4 Bench Top
11.4 Latin America Urinalysis Market (2017-2032) by Country
11.4.1 Brazil
11.4.2 Argentina
11.4.3 Mexico
11.4.4 Others
12 Middle East and Africa Urinalysis Market (2017-2032)
12.1 Middle East and Africa Urinalysis Market (2017-2032) by Product
12.1.1 Market Overview
12.1.2 Instruments
12.1.2.1 Biochemical urine analyzers
12.1.2.2 Automated urine sediment analyzers
12.1.2.3 Point-of-care urine analyzers
12.1.3 Consumables
12.1.3.1 Reagents
12.1.3.2 Disposables
12.1.3.3 Dipsticks
12.1.3.4 Pregnancy and fertility kits
12.2 Middle East and Africa Urinalysis Market (2017-2032) by Applications
12.2.1 Market Overview
12.2.2 Urinary Tract Infections
12.2.3 Kidney Diseases
12.2.4 Diabetes
12.2.5 Liver Diseases
12.2.6 Pregnancy and Fertility
12.2.7 Others
12.3 Middle East and Africa Urinalysis Market (2017-2032) by Modality
12.3.1 Market Overview
12.3.2 Portable
12.3.3 Standalone
12.3.4 Bench Top
12.4 Middle East and Africa Urinalysis Market (2017-2032) by Country
12.4.1 Saudi Arabia
12.4.2 United Arab Emirates
12.4.3 Nigeria
12.4.4 South Africa
12.4.5 Others
13 Regulatory Framework
13.1 Regulatory Overview
13.2 US FDA
13.3 EU EMA
13.4 INDIA CDSCO
13.5 JAPAN PMDA
13.6 Others
14 Patent Analysis
14.1 Analysis by Type of Patent
14.2 Analysis by Publication Year
14.3 Analysis by Issuing Authority
14.4 Analysis by Patent Age
14.5 Analysis by CPC Analysis
14.6 Analysis by Patent Valuation
14.7 Analysis by Key Players
15 Strategic Initiatives
15.1 Analysis by Partnership Instances
15.2 Analysis by Type of Partnership and Collaborations
15.3 Analysis by Joint Ventures
15.4 Analysis by Leading Players
15.5 Analysis by Geography
16 Supplier Landscape
16.1 Market Share Analysis, By Region (Top 5 Companies)
16.1.1 Market Share Analysis: Global
16.1.2 Market Share Analysis: North America
16.1.3 Market Share Analysis: Europe
16.1.4 Market Share Analysis: Asia-Pacific
16.1.5 Market Share Analysis: Others
16.2 Abbott Laboratories
16.2.1 Financial Analysis
16.2.2 Product Portfolio
16.2.3 Demographic Reach and Achievements
16.2.4 Mergers and Acquisitions
16.2.5 Certifications
16.3 Sysmex Corporation
16.3.1 Financial Analysis
16.3.2 Product Portfolio
16.3.3 Demographic Reach and Achievements
16.3.4 Mergers and Acquisitions
16.3.5 Certifications
16.4 ACON Laboratories Inc .
16.4.1 Financial Analysis
16.4.2 Product Portfolio
16.4.3 Demographic Reach and Achievements
16.4.4 Mergers and Acquisitions
16.4.5 Certifications
16.5 Bio-Rad Laboratories Inc .
16.5.1 Financial Analysis
16.5.2 Product Portfolio
16.5.3 Demographic Reach and Achievements
16.5.4 Mergers and Acquisitions
16.5.5 Certifications
16.6 ARKRAY Inc .
16.6.1 Financial Analysis
16.6.2 Product Portfolio
16.6.3 Demographic Reach and Achievements
16.6.4 Mergers and Acquisitions
16.6.5 Certifications
16.7 Siemens AG
16.7.1 Financial Analysis
16.7.2 Product Portfolio
16.7.3 Demographic Reach and Achievements
16.7.4 Mergers and Acquisitions
16.7.5 Certifications
16.8 Thermo Fisher Scientific Inc .
16.8.1 Financial Analysis
16.8.2 Product Portfolio
16.8.3 Demographic Reach and Achievements
16.8.4 Mergers and Acquisitions
16.8.5 Certifications
16.9 77 Elektronika Kft
16.9.1 Financial Analysis
16.9.2 Product Portfolio
16.9.3 Demographic Reach and Achievements
16.9.4 Mergers and Acquisitions
16.9.5 Certifications
16.10 F. Hoffmann-La Roche AG
16.10.1 Financial Analysis
16.10.2 Product Portfolio
16.10.3 Demographic Reach and Achievements
16.10.4 Mergers and Acquisitions
16.10.5 Certifications
16.11 Beckman Coulter, Inc .
16.11.1 Financial Analysis
16.11.2 Product Portfolio
16.11.3 Demographic Reach and Achievements
16.11.4 Mergers and Acquisitions
16.11.5 Certifications
17 Global Urinalysis Market – Distribution Model (Additional Insight)
17.1 Overview
17.2 Potential Distributors
17.3 Key Parameters for Distribution Partner Assessment
18 Key Opinion Leaders (KOL) Insights (Additional Insight)
*Additional insights provided are customisable as per client requirements.
* The coverage of the Market Landscape section depends on the data availability and may cover a minimum of 80% of the total market. The EMR team strives to make this section as comprehensive as possible.
**The supplier list is not exhaustive. Moreover, we can provide analysis of companies as per custom requests.
Datasheet
Single User License
Five User License
Corporate License
Any Question? Speak With An Analyst
View A Sample
Did You Miss Anything, Ask Now
Right People
We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.
Right Methodology
We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.
Right Price
We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.
Right Support
Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.